FDA Adverse Event Other Summary report: N

FOUNDATION KNEE

MDR report key: 2931644 · Received January 24, 2013

Report

Report Number
1644408-2013-00045
Event Type
Other
Date Received
January 24, 2013
Date of Event
January 10, 2013
Report Date
January 10, 2013
Manufacturer
ENCORE MEDICAL, L.P.
Product Code
JWH
PMA / PMN Number
K933539
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
PA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE REASON FOR THIS REVISION SURGERY WAS TO ADDRESS WEAR OF THE PATIENT'S PROSTHETICS AFTER (B)(6) YEARS OF PATIENT USE. THE OUTCOMES ATTRIBUTED TO THIS EVENT ARE REQUIRED INTERVENTION TO PREVENT PERMANENT IMPAIRMENT/DAMAGE. THE HEALTHCARE PROFESSIONAL INDICATED A SIGNIFICANT ADVERSE EVENT TO THE PATIENT. THERE IS NO INFORMATION IN THIS COMPLAINT ABOUT ANY PATIENT INJURIES, ACTIVITIES, ACCIDENTS, OR MEDICAL CONTRAINDICATIONS THAT MAY HAVE CONTRIBUTED TO THE REVISION SURGERY. THERE WAS NO DELAY IN SURGERY AND ANOTHER SUITABLE DEVICE WAS AVAILABLE FOR USE. THE REVISION SURGERY WAS COMPLETED AS INTENDED. THE DEVICE WAS NOT RETURNED TO DJO SURGICAL FOR EXAMINATION. A REVIEW OF THE DEVICE HISTORY RECORDS SHOWED NO NON-CONFORMING MATERIAL REPORTS ASSOCIATED WITH THIS PRODUCT. (B)(4). THE ROOT CAUSE FOR THE REVISION WAS DUE TO NORMAL WEAR. THERE ARE NO INDICATIONS OF A PRODUCT OR PROCESS ISSUE AFFECTING IMPLANT SAFETY OR EFFECTIVENESS.

Description of Event or Problem · 1

REVISION SURGERY - THIS REVISION COVERS THE RIGHT KNEE; THE LEFT KNEE IS REFERENCED IN (B)(4).

Description of Event or Problem · 1

REVISION SURGERY - THE PATIENT HAD BILATERAL ENCORE FOUNDATION KNEES PUT IT ON THE (B)(6) 1998. THE SURGEON REVISED BOTH KNEES INSERTS DUE TO NORMAL WEAR. THE PATIENT HAD 6X9 POSTERIOR STABILIZED TIBIAL INSERTS ON BOTH SIDES; ONE REPLACED WITH SAME SIZE THE OTHER REPLACED WITH 6X11.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
34049 FOUNDATION KNEE POSTERIOR STABILIZED TIBIAL INSERT JWH ENCORE MEDICAL, L.P. 270311

Patients

Seq Age Sex Outcome Treatment
1 67 YR Required Intervention